{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:43:46Z","timestamp":1788288226355,"version":"build-2803163510"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118803","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T20:31:52Z","timestamp":1763843512000},"page":"118803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Therapeutic promise of \u03b1-hederin in Alzheimer\u2019s disease: Insights into inflammation, oxidative stress, and apoptosis modulation"],"prefix":"10.1016","volume":"193","author":[{"given":"Ananda Kumar","family":"Chettupalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5693-2953","authenticated-orcid":false,"given":"Sarad Pawar Naik","family":"Bukke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118803_bib1","first-page":"329","article-title":"Subcellular Biochemistry","author":"Alzheimer\u2019s Disease","year":"2012"},{"key":"10.1016\/j.biopha.2025.118803_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10072-010-0454-7","article-title":"Alzheimer and his disease: a brief history","volume":"32","author":"Cipriani","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.biopha.2025.118803_bib3","first-page":"8","article-title":"Alzheimer\u2019s disease","volume":"31","author":"Blass","year":"1985","journal-title":"Dis. aMon."},{"key":"10.1016\/j.biopha.2025.118803_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/nu14030478","article-title":"Effects of dietary fat to carbohydrate ratio on obesity risk depending on genotypes of circadian genes","volume":"14","author":"Shon","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118803_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jacc.2019.12.034","article-title":"Reply: sex-related differences in heart failure after st-segment elevation myocardial infarction: the role of s-nitrosylation","volume":"75","author":"Bugiardini","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2025.118803_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.biopha.2025.118803_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118803_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An english translation of alzheimer\u2019s 1907 paper, \u201c\u00fcber eine eigenartige erkankung der hirnrinde","volume":"8","author":"Stelzmann","year":"1995","journal-title":"Clin. Anat."},{"key":"10.1016\/j.biopha.2025.118803_bib9","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1002\/alz.13038","article-title":"Association of primary lifetime occupational cognitive complexity and cognitive decline in a diverse cohort: Results from the KHANDLE study","volume":"19","author":"Soh","year":"2023","journal-title":"Alzheimer\u2019S. amp Dement."},{"key":"10.1016\/j.biopha.2025.118803_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2025.118803_bib11","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.mayocp.2017.02.011","article-title":"Alzheimer Disease: Scientific Breakthroughs and Translational Challenges","volume":"92","author":"Caselli","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biopha.2025.118803_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: understanding the Alzheimer\u2019s disease continuum","volume":"9","author":"Aisen","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.biopha.2025.118803_bib13","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2025.118803_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.biopha.2025.118803_bib15","unstructured":"World Alzheimer Report 2016, (n.d.). \u3008https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2016\/\u3009."},{"key":"10.1016\/j.biopha.2025.118803_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/msj.20157","article-title":"Neuropathology of Alzheimer\u2019s disease","volume":"77","author":"Perl","year":"2010","journal-title":"Mt Sinai J. Med"},{"key":"10.1016\/j.biopha.2025.118803_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002093-200210000-00001","article-title":"Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank","volume":"16","author":"Barker","year":"2002","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.biopha.2025.118803_bib18","article-title":"World Alzheimer Report","volume":"2015","author":"Prince","year":"2015","journal-title":"Glob. Impact Dement. Anal. Preval. Incid. Cost. Trends"},{"key":"10.1016\/j.biopha.2025.118803_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Dominantly Inherited Alzheimer Network, Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118803_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ncl.2017.01.005","article-title":"Early-Onset Alzheimer Disease","volume":"35","author":"Mendez","year":"2017","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.biopha.2025.118803_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118803_bib22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","article-title":"Dementia in Down\u2019s syndrome","volume":"15","author":"Ballard","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2025.118803_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2025.118803_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118803_bib25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat. Genet"},{"key":"10.1016\/j.biopha.2025.118803_bib26","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.biopha.2017.11.047","article-title":"Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer\u2019s disease","volume":"97","author":"Kheradmand","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118803_bib27","article-title":"Alzheimer\u2019s disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimers Dement (N. Y"},{"key":"10.1016\/j.biopha.2025.118803_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118803_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ddc4020022","article-title":"Pathophysiology of Alzheimer\u2019s Disease: Focus on H3 Receptor Modulators and Their Implications","volume":"4","author":"Bandaru","year":"2025","journal-title":"DDC"},{"key":"10.1016\/j.biopha.2025.118803_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopha.2025.118803_bib31","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10571-017-0468-2","article-title":"Piracetam Attenuates LPS-Induced Neuroinflammation and Cognitive Impairment in Rats","volume":"37","author":"Tripathi","year":"2017","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118803_bib32","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1007\/s12013-024-01400-y","article-title":"Neuroprotective Effects of Dehydroepiandrosterone and Hericium erinaceus in Scopolamine-induced Alzheimer\u2019s Diseases-like Symptoms in Male Rats","volume":"82","author":"Shirvani","year":"2024","journal-title":"Cell Biochem Biophys."},{"key":"10.1016\/j.biopha.2025.118803_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12576-015-0367-6","article-title":"The protective effect of \u03b1-hederin, the active constituent of Nigella sativa, on tracheal responsiveness and lung inflammation in ovalbumin-sensitized guinea pigs","volume":"65","author":"Saadat","year":"2015","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.biopha.2025.118803_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/1028415X.2016.1144846","article-title":"Hesperidin ameliorates cognitive dysfunction, oxidative stress and apoptosis against aluminium chloride induced rat model of Alzheimer\u2019s disease","volume":"20","author":"Justin Thenmozhi","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.biopha.2025.118803_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14421\/biomedich.2024.131.7-33","article-title":"The Neuroprotective and Therapeutic Effects of Medicinal Plants and Natural Products against Aluminium Chloride-Induced Alzheimer\u2019s Disease: Recent Update","volume":"13","author":"Ojetunde","year":"2024","journal-title":"BIOMEDNATPROCH"},{"key":"10.1016\/j.biopha.2025.118803_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.etap.2015.08.008","article-title":"Neuroprotective effects of \u03b1-iso-cubebenol on glutamate-induced neurotoxicity","volume":"40","author":"Park","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118803_bib37","article-title":"Alpha-Hederin induces incomplete autophagic injury in non-small cell lung cancer by interfering with the lysosomal acidification","volume":"14","author":"Jin","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118803_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11101-010-9183-z","article-title":"Saponins as cytotoxic agents: a review","volume":"9","author":"Podolak","year":"2010","journal-title":"Phytochem Rev."},{"key":"10.1016\/j.biopha.2025.118803_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.biopha.2025.118803_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118803_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2025.118803_bib42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118803_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2025.118803_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12974-019-1490-8","article-title":"Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin 1 beta","volume":"16","author":"Sheppard","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2025.118803_bib45","first-page":"17","article-title":"Resveratrol Attenuates Subacute Systemic Inflammation-Induced Spatial Memory Impairment via Inhibition of Astrocyte Activation and Enhancement of Synaptophysin Expression in the Hippocampus","volume":"47","author":"Chen","year":"2017","journal-title":"Ann. Clin. Lab Sci."},{"key":"10.1016\/j.biopha.2025.118803_bib46","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11064-012-0708-2","article-title":"Neuroinflammation and synaptic loss","volume":"37","author":"Rao","year":"2012","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.biopha.2025.118803_bib47","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1046\/j.1471-4159.1998.70041584.x","article-title":"Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system","volume":"70","author":"Casta\u00f1o","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118803_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-5-37","article-title":"Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation","volume":"5","author":"Lee","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2025.118803_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0969-9961(03)00069-X","article-title":"V.E. Koliatsos, Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice","volume":"14","author":"Sheng","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2025.118803_bib50","first-page":"86","article-title":"Lipopolysaccharide endotoxemia induces amyloid-\u03b2 and p-tau formation in the rat brain","volume":"8","author":"Wang","year":"2018","journal-title":"Am. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.biopha.2025.118803_bib51","doi-asserted-by":"crossref","first-page":"39904","DOI":"10.1074\/jbc.M111.267583","article-title":"Neuronal death induced by nanomolar amyloid \u03b2 is mediated by primary phagocytosis of neurons by microglia","volume":"286","author":"Neniskyte","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118803_bib52","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9440(10)65423-5","article-title":"Association of microglia with amyloid plaques in brains of APP23 transgenic mice","volume":"154","author":"Stalder","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2025.118803_bib53","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1523\/JNEUROSCI.4814-07.2008","article-title":"Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance","volume":"28","author":"Bolmont","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118803_bib54","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118803_bib55","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41467-019-09046-8","article-title":"Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118803_bib56","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0891-5849(96)00501-1","article-title":"Redox regulation of NF-kappa B activation","volume":"22","author":"Floh\u00e9","year":"1997","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2025.118803_bib57","doi-asserted-by":"crossref","first-page":"11527","DOI":"10.1073\/pnas.91.24.11527","article-title":"Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway","volume":"91","author":"Anderson","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118803_bib58","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fphar.2018.01162","article-title":"Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases","volume":"9","author":"Tan","year":"2018","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118803_bib59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","article-title":"TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy","volume":"12","author":"Bemiller","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2025.118803_bib60","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118803_bib61","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-131843","article-title":"Tau oligomers and fibrils induce activation of microglial cells","volume":"37","author":"Morales","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.118803_bib62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/brain\/awt323","article-title":"Fractalkine activates NRF2\/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis","volume":"137","author":"Lastres-Becker","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.118803_bib63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","article-title":"Intersection of pathological tau and microglia at the synapse","volume":"7","author":"Vogels","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.biopha.2025.118803_bib64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20142322","article-title":"TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models","volume":"212","author":"Jay","year":"2015","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2025.118803_bib65","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fphar.2019.00902","article-title":"Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update","volume":"10","author":"Cenini","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118803_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/cells14030229","article-title":"Mitochondrial Alterations, Oxidative Stress, and Therapeutic Implications in Alzheimer\u2019s Disease: A Narrative Review","volume":"14","author":"Spina","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118803_bib67","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbalip.2010.03.007","article-title":"Membrane rafts in Alzheimer\u2019s disease beta-amyloid production","volume":"1801","author":"Vetrivel","year":"2010","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.118803_bib68","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis","volume":"20","author":"Swerdlow","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.118803_bib69","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neurobiolaging.2007.12.005","article-title":"Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice","volume":"30","author":"Hauptmann","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2025.118803_bib70","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer\u2019s disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118803_bib71","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1471-4159.2007.05072.x","article-title":"Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein","volume":"104","author":"Tamagno","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118803_bib72","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bcp.2014.01.015","article-title":"Pathogenesis of synaptic degeneration in Alzheimer\u2019s disease and Lewy body disease","volume":"88","author":"Overk","year":"2014","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118803_bib73","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1074\/mcp.RA118.001290","article-title":"Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer\u2019s Disease Cerebrospinal Fluid","volume":"18","author":"Lle\u00f3","year":"2019","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.biopha.2025.118803_bib74","article-title":"Antioxioxidant and antiapoptotic effects of Thymosin \u03b24 in A\u03b2-induced SH-SY5Y cells via the 5-HTR1A\/ERK axis","volume":"18","author":"Zhang","year":"2023","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2025.118803_bib75","first-page":"103","article-title":"Ganoderic Acids A and B Reduce Okadaic Acid-Induced Neurotoxicity in PC12 Cells by Inhibiting Tau Hyperphosphorylation","volume":"36","author":"Cui","year":"2023","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.biopha.2025.118803_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2010.08.077","article-title":"An okadaic acid-induced model of tauopathy and cognitive deficiency","volume":"1359","author":"Zhang","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.biopha.2025.118803_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial Dysfunction and Oxidative Stress in Alzheimer\u2019s Disease","volume":"13","author":"Misrani","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.biopha.2025.118803_bib78","author":"Zhang","year":"2022","journal-title":"Label. Free Vis. amyloid Plaques Alzheimer\u2019S. Dis. Polariz. sensitive Photoacoust. Mueller Matrix Tomogr."},{"key":"10.1016\/j.biopha.2025.118803_bib79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.118803_bib80","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118803_bib81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on Alzheimer\u2019s disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.biopha.2025.118803_bib82","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1007\/s12035-021-02338-5","article-title":"A New Approach to Model Sporadic Alzheimer\u2019s Disease by Intracerebroventricular Streptozotocin Injection in APP\/PS1 Mice","volume":"58","author":"Kelliny","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118803_bib83","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JAD-2009-1184","article-title":"Modeling sporadic Alzheimer\u2019s disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-b","volume":"18","author":"Salkovic-Petrisic","year":"2009","journal-title":"eta J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.biopha.2025.118803_bib84","article-title":"Donepezil for dementia due to Alzheimer\u2019s disease","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2025.118803_bib85","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118803_bib86","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4103\/1673-5374.230303","article-title":"Use of curcumin in diagnosis, prevention, and treatment of Alzheimer\u2019s disease","volume":"13","author":"Chen","year":"2018","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.biopha.2025.118803_bib87","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s12035-018-1157-y","article-title":"Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement","volume":"56","author":"Corpas","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118803_bib88","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2021.3854","article-title":"Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility","volume":"325","author":"Alexander","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118803_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/aei.v52i1.963","article-title":"Resveratrol modulates the Nrf2\/NF-\u03baB pathway and inhibits TSLP-mediated atopic march","volume":"52","author":"He","year":"2024","journal-title":"Allergol. Immunopathol."},{"key":"10.1016\/j.biopha.2025.118803_bib90","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/01616412.2023.2296754","article-title":"Minocycline mitigates tau pathology via modulating the TLR-4\/NF-\u043a\u03b2 signalling pathway in the hippocampus of neuroinflammation rat model","volume":"46","author":"Abdo Qaid","year":"2024","journal-title":"Neurol. Res."},{"key":"10.1016\/j.biopha.2025.118803_bib91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118803_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1408462","article-title":"Molecular mechanisms and therapeutic potential of lithium in Alzheimer\u2019s disease: repurposing an old class of drugs","volume":"15","author":"Shen","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118803_bib93","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jnc.15842","article-title":"The polyphenol EGCG directly targets intracellular amyloid-\u03b2 aggregates and promotes their lysosomal degradation","volume":"166","author":"Secker","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118803_bib94","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1523\/JNEUROSCI.1521-05.2005","article-title":"Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice","volume":"25","author":"Rezai-Zadeh","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118803_bib95","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.52041","article-title":"Evidence-Based Complementary and Alternative Medicine in Current Medical Practice","author":"Mortada","year":"2024","journal-title":"Cureus 16"},{"key":"10.1016\/j.biopha.2025.118803_bib96","series-title":"Oxidative Medicine and Cellular Longevity","author":"Vasquez-Vivar","year":"2018"},{"key":"10.1016\/j.biopha.2025.118803_bib97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"ARGO investigators, A phase II trial of tideglusib in Alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.118803_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118803_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1228030","article-title":"Bioanalytical method validation and application to a phase 1, double-blind, randomized pharmacokinetic trial of a standardized Centella asiatica (L.) Urban water extract product in healthy older adults","volume":"14","author":"Wright","year":"2023","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118803_bib100","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118803_bib101","article-title":"Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: a comprehensive review","volume":"15","author":"Ma","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118803_bib102","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ptr.5591","article-title":"A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies","volume":"30","author":"Izzo","year":"2016","journal-title":"Phytother. Res"},{"key":"10.1016\/j.biopha.2025.118803_bib103","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118803_bib104","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1055\/s-0031-1298331","article-title":"Pharmacokinetic Herb-Drug Interactions (Part 2): Drug Interactions Involving Popular Botanical Dietary Supplements and Their Clinical Relevance","volume":"78","author":"Gurley","year":"2012","journal-title":"Planta Med"},{"key":"10.1016\/j.biopha.2025.118803_bib105","first-page":"109","article-title":"Defining Disease Modifying Therapy for Alzheimer\u2019s Disease","author":"Cummings","year":"2017","journal-title":"J. Prev. Alzheimers Dis. 4"},{"key":"10.1016\/j.biopha.2025.118803_bib106","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2025.118803_bib107","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer\u2019s disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.biopha.2025.118803_bib108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trci.2016.12.003","article-title":"Active A\u03b2 immunotherapy CAD106 in Alzheimer\u2019s disease: A phase 2b study","volume":"3","author":"Vandenberghe","year":"2017","journal-title":"Alzheimers Dement (N. Y"},{"key":"10.1016\/j.biopha.2025.118803_bib109","article-title":"Alzheimer\u2019s disease drug development pipeline: 2020","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimers Dement (N. Y"},{"key":"10.1016\/j.biopha.2025.118803_bib110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimers Res Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:14:10Z","timestamp":1777014850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":110,"alternative-id":["S0753332225009977"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118803","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic promise of \u03b1-hederin in Alzheimer\u2019s disease: Insights into inflammation, oxidative stress, and apoptosis modulation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118803"}}